Navigation Links
Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
Date:3/26/2008

arma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at http://www.bayerscheringpharma.de.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Contact Details

Bayer HealthCare

Oliver Renner, Tel: +49-30-468-12431

Head Global Public Relations & Public Affairs

oliver.renner@bayerhealthcare.com

MEDRAD

Luanne Radermacher, Tel: +1-724-940-7968

Director, Corporate Affairs

lradermacher@medrad.com


'/>"/>
SOURCE Bayer HealthCare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
2. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
3. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
4. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
7. LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems
8. Caliper Life Sciences to Present at Lehman Brothers Global Healthcare Conference
9. Misys and Allscripts Create a Leader in Healthcare Software
10. Angiotech to participate in Lehman Brothers Healthcare Conference
11. Kendle to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
(Date:1/22/2015)... January 22, 2015 Shimadzu Scientific ... UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength scanning from ... is ideal for applications in a variety of ... , The user-friendly UV-1280 enables intuitive operation, while ...
(Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
(Date:1/22/2015)... Protocol Networks brings independent technology consulting ... brand-neutral, independent consultants, Protocol Networks has recently announced its ... the years, his company has attracted several clients in ... as well as others. With the success of these ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO ... release financial results for the third quarter and first nine ... after market close in the US.   The ... Monday, February 28, 2011 to discuss its financial performance and ...
... traditional materials and enables the development of innovative ... about the safety aspects and to what extent ... basis for reliable safety assessments, process improvement, quality ... , Until now, however, no certified benchmarks ...
... astronomers to sharpen images of celestial bodies can now help ... brain of a mouse. Eric Betzig, a group leader at ... present his team,s latest work using adaptive optics for biology ... Advancement of Science in Washington, D.C. during a press conference ...
Cached Biology Technology:China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results 2First certified reference material for nanoparticle size analysis 2First certified reference material for nanoparticle size analysis 3Improving microscopy by following the astronomers' guide star 2Improving microscopy by following the astronomers' guide star 3Improving microscopy by following the astronomers' guide star 4
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its ... the G2 model. The G2 sets a higher standard for ... human capital management solution. With plug-and-play installation, touch screen interface ... clock provides a robust time collection solution for the small ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics Agency is ... and prevent counterfeit microcircuits from entering into its supply ... in-house microcircuit anti-counterfeit initiative dubbed DNA marking. The capability ... their reliability throughout the supply chain. The new quality ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... chronic coughs, soot or black carbon turns out ... second only to carbon dioxide, according to a four-year assessment ... carbon, the soot particles in smoke and smog, contributes about ... by the 2007 Intergovernmental Panel on Climate Change. "We were ...
... industry faces a global problem with antibiotic resistance, a ... diseases may not work when needed and creating ... The risk to humans is probably minor unless ... systems, researchers said, although transmission of disease from tropical ...
... initiative to understand chronic disease in Africa has been ... (MRC). The African Partnership for Chronic Disease Research (APCDR) ... and causes of non-communicable diseases such as diabetes and ... will allow researchers from the partnership to develop a ...
Cached Biology News:International study: Where there's smoke or smog, there's climate change 2International study: Where there's smoke or smog, there's climate change 3Ornamental fish industry faces increasing problems with antibiotic resistance 2Ornamental fish industry faces increasing problems with antibiotic resistance 3Chronic disease research awarded funding 2Chronic disease research awarded funding 3